PHAR2220 Lecture Notes - Lecture 23: Cytostasis, Breast Cancer, Retinoblastoma Protein
`TOPIC'7:'CANCER:'
'
Lecture'17:'Pathogenesis'of'Cancer:'
!
Definitions'and'Basic'Concepts:'
'
"#$%&'(!
)!"#$%&'!*!+&$&'#,!-&'.!/0'!1233!456&6!
)!7,,!#'&!%8#'#%-&'56&4!9:!;$%0$-'0,,&4!+'0<-8!0/!+&$&-5%#,,:!#,-&'&4!%&,,6!
)!=8&!'&6;,-5$+!-;.0;'>$&0?,#6.!<5,,!&@&$-;#,,:!5$@#4&!A!4&6-'0:!6;''0;$45$+!-566;&!B!,0%#,,:!
5$@#65@&!
)!"#$%&'!%&,,6!#,60!6?'!@5#!9,004!0'!,:.?8!-0!%0,0$56&!456-#$-!0'+#$6!*!.&-#6-#656!
)!7!-;.0;'!$0-!&C8595-5$+!5$@#65@&!0'!.&-#6-#-5%!9&8#@50;'!56!-&'.&4!9&$5+$!D@6!.#,5+$#$-E!
!
=;.0;'!F5-&6!5$!-8&!G;.#$!H04:(!
)!"&,,6!5$!#$:!0/!-8&!IJ33!-566;&!-:?&6!5$!-8&!904:!%#$!?0-&$-5#,,:!9&%0.&!%#$%&'0;6!
)!=;.0;'6!5$!-566;&6!/0'.!,;.?6!*!60,54!-;.0;'6!
)!=;.0;'6!5$@0,@5$+!9,004!%&,,6!*!K,5L;54!-;.0;'6M!*!,&;N#&.5#6!
!
!
!
"#$%&'!5$!7;6-'#,5#(!
)!IOPQ333!%#$%&'!4&#-86>:&#'!
)!J(O!.&$Q!J(R!<0.&$!9:!#+&!ST!
)!"0..0$&6-!56!$0$).&,#$0.#!6N5$!%#$%&'!D1OSRQ333!%#6&6>:&#'!9;-!-'&#-#9,&E!
)!=8&!KH5+!OM!,-$+!/#-#,!-;.0;'6!5$!#4;,-6(!
o!U&$(!V'06-#-&Q!,;$+Q!%0,0'&%-#,!
o!W0.&$(!9'-Q!,;$+Q!%0,0'&%-#,!
)!"#$%&'!'56N!5$%'&6!<5-8!#+&!D9;-!#,,!#+&6!#'&!6;6%&?-59,&E!
)!"#$%&'!56!0$!-8&!'56&!
!
X'5+5$6!0/!"#$%&'(!
)!F0.&!%#$%&'!'#-&6!40!$0-!@#':!/'0.!%0;$-':!-0!%0;$-':!!
o!U#$:!?#&45#-'5%!-;.0;'6!D9#6#,!.;-#-50$!'#-&E!
)!H;-!.06-!%#$%&'!'56N!@#'5&6!+'&#-,:(!
o!U&,#$0.#!B!7;6!JTTC!Y#?#$!
o!F-0.#%8!B!Y#?#$!PC!ZF!
o![5@&'!B!"85$#!T3C!"#$#4#!
)!=8&!+'&#-!.#\0'5-:!0/!%0..0$!%#$%&'6!#'&!2$4!-0!&C-&'$#,!/#%-0'6!D&]+]!6.0N5$+E!#$4!#'&!$0-!
5$8&'5-&4!
)!^&6?5-&!&C?06;'&!-0!%#'%5$0+&$5%!/#%-0'6Q!?&0?,&!40$M-!4&@&,0?!0@&'-!%#$%&'!/0'!.#$:!4&%#4&6!
HZ=!%#$%&'!5$%54&$%&!6--,:!5$%'&6!<5-8!#+&_!
How'Cancer'Develops:'
!
)!=8&!904:!8#6!#!$;.9&'!0/!@&':!&//&%-5@&!5$-'5$65%!4&/&$%&6!-0!/5+8-!0//!%#$%&'!4&@&,0?.&$-Q!9;-!
&@&$-;#,,:!-8&6&!4&/&$%&!.&%8#$56.6!#'&!0@&'%0.&Q!F=`V!Ha!F=`V!
!
"#$%&'!56!#!U;,-56-&?!V'0%&66(!
)!H&+5$6!<5-8!.;-#-50$!5$!#!65$+,&!%&,,!*!K5$5-5#-&4!%&,,M!!
)!b$5-5#-&4!%&,,!?'0,5/&'#-50$!'#-&!85+8!!!%,0$#,!&C?#$650$!<5-8!?'0+&$:!#%L;5'5$+!/;'-8&'!.;-#-50$6!
B!?'0.0-50$!
)!"'5-5%#,!5''&@&'659,&!.;-#-50$!B!.#,5+$#$-!%0$@&'650$!
)!V'0+&$:!%0$-5$;&!-0!.;-#-&!B!?'0+'&6650$!
!
!
!
W8:!#'&!60!.#$:!.;-#-50$6!$&&4&4c!
)!=;.0;'!%&,,6!#%%;.;,#-&!.;-#-50$6!D%#?#95,5-5&6E!5$!#!6-&?<56&!.#$$&'!-0!&@#4&!$0'.#,!%8&%N6!
#$4!9#,#$%&6!0$!%&,,!+'0<-8Q!4&#-8!#$4!.0@&.&$-!
)!U;-#-50$6!0%%;'!5$!#!,5.5-&4!$;.9&'!0/!N&:!+&$&6!
)!7-!,-!d!$&<!%#?#95,5-5&6!D6-&?6E!#'&!'&L;5'&4!
!
F5C!"#?#95,5-5&6!0/!"#$%&'!"&,,6(!
J]!F&,/)6;//5%5&$-!5$!+'0<-8!DeE!65+$#,6!
2]!b$6&$65-5@&!-0!+'0<-8!5$8595-0':!D)E!65+$#,6!
O]!"#$!&@#4&!%&,,!4&#-8!D#?0?-0656E!
R]!"#$!?'0,5/&'#-&!5$4&/5$5-&,:!D#$+50+&$&656E!
T]!"#$!6?'!#<#:!/'0.!?'5.#':!-;.0;'!D5$@#650$!A!
.&-#6-#656E!
!
)!"#$%&'!.;-#-50$6!-#'+&-!0$&!0'!.0'&!0/!-8&6&!d!%#?#95,5-5&6!
-0!9'&#%8!%&,,;,#'!4&/&$%&6!
)!7,,!d!%#?#95,5-5&6!.;6-!9&!0@&'%0.&!-0!?'04;%&!#$!5$@#65@&!
%#$%&'!
!
f0'.#,!g'0<-8!"0$-'0,(!
)!=0!.#5$-#5$!$0'.#,!-566;&!#'%85-&%-;'&Q!%&,,6!.;6-!45@54&!0$,:!<8&$!5-!56!#??'0?'5#-&!-0!40!60!
)!f0'.#,!%&,,6!#'&!L;5&6%&$-!Dg3E!;$-5,!-8&:!'&%&5@&!.5-0+&$5%!65+$#,6!/'0.!-8&!K$&5+890;'8004M!
)!g'0<-8!/#%-0'6!DghE!5$6-';%-!%&,,6!-0!?'0,5/&'#-&!B!&$-&'!-8&!%&,,!%:%,&!DgJ!FE!
)!gh6!65+$#,!@5#!'&%&?-0'6!Dgi)iE!B!0/-&$!-:'065$&!N5$#6&!65+$#,!-'#$64;%&'6!-8#-!%0$@&'-!`"!b"!
65+$#,!
)!f&5+890;'5$+!%&,,6!#,60!'&,&!+'0<-8!5$8595-0':!/#%-0'6!
Breaching'a'Cell’s'AntiFCancer'Defences'–'Step'by'Step:'
!
g'0<-8!h#%-0'!F5+$#,,5$+(!
J]!gh!B!,5+#$4!D`"E!
2]!gh)i!B!i=j!
O]!b"!65+$#,,5$+!%#6%#4&!
R]!7%-5@#-50$!0/!-#'+&-!?'0-&5$6!
T]!V806?80':,#-50$!eee!
)!F5+$#,,5$+!%#$!9&!%0)0?-&4!#-!#$:!6-&?!5$!-8&!65+$#,!-'#$64;%-50$!'0;-&!!!Z$%0$-'0,,&4!
?'0,5/&'#-50$!
!
Tumour'Capability'1:'Self'Sufficient'in'Growth'Signals:'
)!"#$%&'!%&,,6!!!4&%!4&?&$4&$%:!0$!gh6!/0'!-8&5'!+'0<-8!#$4!6;'@5@#,!
)!X$%0+&$&!#%-5@#-50$!B!-;.0;'!?'04;%&6!0<$!+'0<-8!65+$#,6(!
o!7;-0%'5$&!gh!?'04;%-50$!DV^gh!B!+,509,#6-0.#E!
o!X@&')&C?'&6650$!0/!gh)i!D`ghi!B!9'-Q!6-0.#%8E!
o!"0$6-5-;-5@&!#%-5@#-50$!0/!gh)i!D`ghiE!
o!"0$6-5-;-5@&!#%-5@#-50$!0/!5$-'#%&,,;,#'!65+$#,,5$+!
"!i#6>i#/>U7Vj!?'0,5/&'#-50$!?#-8<#:!D.#$:!%#$%&'6E!
"!VbOj>7-N!+'0<-8>6;'@5@#,!?#-8<#:!DVbOj!B!9'-Q!"i"E!
!
)!H'&#%8!kJ!*!%&,,6!?'0,5/&'#-&!5$4&?&$4&$-,:!0/!+'0<-8!/#%-0'6!
!
Tumour'Capability'2:'Insensitive'to'Growth'Inhibition:'
)!f0'.#,!%&,,6!'&6?0$4!-0!#$-5)?'0,5/&'#-5@&!65+$#,6!B!6&$6&!5/!5-6!Xj!/0'!45@5650$!-0!+0!#8!!!
9'&#N!
)!U#$:!0/!-8&6&!65+$#,6!#'&!'0;-&4!-8'0;+8!-;.0;'!6;??'&660'6!5]&]!
?'04;%-6!0/!#$-5)0$%0+&$&6!
)!H'#N&6!%0..0$,:!'&+;,#-&!-8&!%&,,!%:%,&!#$4!&5-8&'(!
o!h0'%&!%&,,6!0;-!0/!%&,,!%:%,&!#$4!5$-0!g3!Xi!
o!b$4;%&!%&,,6!-0!&$-&'!#!?06-).5-0-5%!6-#-&!D5]&]!;$4&'+0!
-&'.5$#,!45//&'&$-5#-50$!
!
g'0<-8!b$8595-0':!F5+$#,6!5$!-8&!"&,,!":%,&(!
)!g&$&6!&$%045$+!-8&6&!65+$#,,5$+!?'0-&5$6!!!=;.0;'!F;??'&660'!g&$&6!D=Fg6E!
o!"#$%&'!%&,,6!%#$!&@#4&!-8&6&!#$-5)?'0,5/&'#-5@&!65+$#,6!5$!6&@&'#,!<#:6!
o!U#$:!/#.5,5#,!%#$%&'6!#'&!4;&!-0!5$8&'5-#$%&!0/!0$&!.;-#-&4!=Fg!#,,&,&!
o!U06-!#$-5)?'0,5/&'#-5@&!65+$#,6!/;$$&,!-8'0;+8!i9!D'&-5$09,#6-0.#!?'0-&5$E!B!i9!?#-8<#:!
56!456';?-&4!5$!.06-!8;.#$!-;.0;'6!
!
)!H'&#%8!k2!*!-;.0;'6!40!$0-!'&6?0$4!-0!+'0<-8!5$8595-50$!
!
Tumour'Capability'3:'Evasion'of'Cell'Death'(apoptosis):'
)!=Fg6!6;??'&66!?'0,5/&'#-50$!9:!&5-8&'(!
o!^&%!?'0,5/&'#-50$!D4&%!%&,,!?'04;%-50$E!
o!b$%!#?0?-0656!D5$%!%&,,!,066E!
)!7?0?-0656!*!?'0+'#..&4!%&,,!4&#-8!
o!"#'&/;,,:!0'%8&6-'#-&4!?'0%&66!B!%&,,!6-';%-;'&6!4&+'#4&4Q!$;%,&;6!/'#+.&$-&4Q!%&,,!
%0'?6&!&$+;,/&4!D,&#@&6!$0!6%#''5$+E!
o!`66&$-5#,!/0'!$0'.#,!4&@&,0?.&$-!B!.0'?80+&$&656!
